We are live on
!
Find out more
KCM
Kendall Capital Management Portfolio holdings
AUM
$488M
1-Year Est. Return
28.68%
This Fund
S&P 500
This Quarter
Est. Return
-11.66%
1 Year Est. Return
+28.68%
3 Year Est. Return
+84.44%
5 Year Est. Return
+102.56%
10 Year Est. Return
–
AUM
$182M
AUM Growth
-$25.3M
(-12%)
Cap. Flow
+$683K
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
175
New
13
Increased
56
Reduced
67
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Bancorp
CBNK
|
+$1.64M |
| 2 |
iShares Russell 2500 ETF
SMMD
|
+$965K |
| 3 |
iShares Micro-Cap ETF
IWC
|
+$946K |
| 4 |
Medifast
MED
|
+$520K |
| 5 |
Diodes
DIOD
|
+$475K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$3.9M |
| 2 |
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
|
+$1.64M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$496K |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$483K |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$475K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Healthcare | 14.71% |
| 3 | Financials | 12.43% |
| 4 | Industrials | 9.3% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
J.M. Smucker
SJM
$12.7B
| $360K | 0.2% |
2,815
-100
| -3% | -$13.3K |
|
127
MetLife
MET
$63.7B
| $358K | 0.2% |
5,702
| – | – |
|
128
Emergent Biosolutions
EBS
$272M
| $354K | 0.2% |
11,395
-190
| -2% | -$6.49K |
|
129
Moody's
MCO
$81.9B
| $349K | 0.19% |
1,285
-130
| -9% | -$38.9K |
|
130
Kraft Heinz
KHC
$29.6B
| $338K | 0.19% |
8,870
+315
| +4% | +$12.6K |
|
131
Corpay
CPAY
$26B
| $335K | 0.18% |
1,595
| – | – |
|
132
Brookfield Infrastructure
BIPC
$4.87B
| $333K | 0.18% |
+7,840
| New | +$371K |
|
133
CACI
CACI
$13.9B
| $333K | 0.18% |
1,180
| – | – |
|
134
McKesson
MCK
$102B
| $316K | 0.17% |
970
| – | – |
|
135
Carlyle Group
CG
$17.6B
| $298K | 0.16% |
+9,405
| New | +$360K |
|
136
Brighthouse Financial
BHF
$3.57B
| $289K | 0.16% |
7,050
| – | – |
|
137
Icon
ICLR
$12.4B
| $281K | 0.15% |
1,298
-20
| -2% | -$4.49K |
|
138
Novartis
NVS
$293B
| $278K | 0.15% |
3,293
-125
| -4% | -$11K |
|
139
Winnebago Industries
WGO
$885M
| $276K | 0.15% |
5,675
-75
| -1% | -$3.88K |
|
140
Verizon
VZ
$195B
| $272K | 0.15% |
5,355
-891
| -14% | -$45.1K |
|
141
Danaher
DHR
$141B
| $271K | 0.15% |
1,207
| – | – |
|
142
Consensus Cloud Solutions
CCSI
$687M
| $268K | 0.15% |
6,130
-716
| -10% | -$35.6K |
|
|
DOOR
143
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $265K | 0.15% |
3,455
| – | – |
|
144
iShares Russell 1000 ETF
IWB
$49.7B
| $264K | 0.15% |
1,272
-95
| -7% | -$21.5K |
|
|
BECN
145
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $262K | 0.14% |
5,100
| – | – |
|
|
HAPN
146
Happen Inc
HAPN
$2.27B
| $259K | 0.14% |
+22,155
| New | +$312K |
|
147
AMN Healthcare
AMN
$1.19B
| $255K | 0.14% |
+2,321
| New | +$230K |
|
148
Lam Research
LRCX
$383B
| $253K | 0.14% |
5,930
| – | – |
|
149
AstraZeneca
AZN
$250B
| $250K | 0.14% |
1,896
| – | – |
|
150
Chevron
CVX
$371B
| $249K | 0.14% |
1,719
| – | – |
|
Similar funds
HL
UOIF
ACM
GCM
SCA
PE
IP
MA
Kendall Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Kendall Capital Management held 175 positions worth $182M, down 12% from $207M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Kendall Capital Management's Q2 2022 filing shows 13 new, 56 increased, 67 reduced and 7 closed positions. Its largest new stake was Diodes: 6,515 shares worth $421K. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $3.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Kendall Capital Management's largest Q2 2022 buy was Diodes: 6,515 shares worth $421K.
- Kendall Capital Management added most to Capital Bancorp in Q2 2022, an estimated $1.64M increase.
- Kendall Capital Management's biggest Q2 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $3.9M.
- Kendall Capital Management fully exited Tivity Health, Inc. Common Stock in Q2 2022, selling an estimated $496K.
- Kendall Capital Management's ten largest holdings make up 25% of its $182M portfolio in Q2 2022.
- Kendall Capital Management opened 13 new positions and closed 7 in Q2 2022.
- Kendall Capital Management's portfolio value fell 12% quarter-over-quarter to $182M.
Based on Kendall Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.